ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 61 filers reported holding ZAI LAB LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $714,277 | -17.0% | 29,382 | -5.3% | 0.00% | – |
| Q2 2023 | $860,712 | +15.3% | 31,039 | +27.7% | 0.00% | – |
| Q4 2022 | $746,194 | +46.9% | 24,306 | +63.5% | 0.00% | – |
| Q3 2022 | $508,000 | -82.9% | 14,863 | -78.0% | 0.00% | -100.0% |
| Q1 2022 | $2,974,000 | +9.3% | 67,608 | +56.2% | 0.00% | – |
| Q4 2021 | $2,722,000 | -84.1% | 43,290 | -73.4% | 0.00% | -100.0% |
| Q3 2021 | $17,164,000 | -30.9% | 162,855 | +16.0% | 0.01% | -22.2% |
| Q2 2021 | $24,841,000 | +323.4% | 140,351 | +219.2% | 0.01% | +200.0% |
| Q1 2021 | $5,867,000 | +327.3% | 43,973 | +333.4% | 0.00% | – |
| Q4 2020 | $1,373,000 | -33.3% | 10,146 | -59.0% | 0.00% | -100.0% |
| Q3 2020 | $2,059,000 | +258.1% | 24,753 | +253.6% | 0.00% | – |
| Q2 2020 | $575,000 | +96.2% | 7,000 | +22.9% | 0.00% | – |
| Q1 2020 | $293,000 | -58.6% | 5,696 | -84.3% | 0.00% | -100.0% |
| Q3 2018 | $707,000 | – | 36,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRILLIANCE ASSET MANAGEMENT LTD | 1,631,887 | $71,770,000 | 28.24% |
| Zeal Asset Management Ltd | 351,829 | $15,234,000 | 19.86% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $20,231,000 | 11.97% |
| INDUS CAPITAL PARTNERS, LLC | 291,026 | $12,799,000 | 5.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $16,958,000 | 3.82% |
| HSG Holding Ltd | 694,634 | $30,550,000 | 3.81% |
| EcoR1 Capital, LLC | 2,223,212 | $97,777,000 | 3.06% |
| Segantii Capital Management Ltd | 2,252,274 | $99,055,000 | 2.86% |
| Privium Fund Management B.V. | 226,752 | $9,973,000 | 2.20% |
| Genesis Investment Management, LLP | 820,352 | $36,079,000 | 2.12% |